Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.
The association between oral bisphosphonate use and upper gastrointestinal cancer has been controversial. Therefore, we examined the association with esophageal and gastric cancer within the Kaiser Permanente, Northern California population. A total of 1,011 cases of esophageal (squamous cell carcin...
Main Authors: | Emily Vogtmann, Douglas A Corley, Lucy M Almers, Chris R Cardwell, Liam J Murray, Christian C Abnet |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4596624?pdf=render |
Similar Items
-
Risk of severe upper gastrointestinal complications among oral bisphosphonate users.
by: Arianna Ghirardi, et al.
Published: (2013-01-01) -
A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers.
by: Sonja P Dawsey, et al.
Published: (2014-01-01) -
The Effects of Bisphosphonate Therapy on Upper Gastrointestinal Tract in Postmenopausal Women: A Preliminary Report
by: Zeliha Ünlü, et al.
Published: (2002-09-01) -
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
by: Joan C. Lo, et al.
Published: (2020-12-01) -
Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
by: Ellen Wright, et al.
Published: (2012-01-01)